World's Best Scientists 2026 revealed!
Toshio Ogihara

Toshio Ogihara

Award Badge
Medicine
Japan
2023

D-Index & Metrics

Medicine

D-Index
128
Citations
62182
World Ranking
2708
National Ranking
52

Toshio Ogihara publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Toshio Ogihara sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,509 publications — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Toshio Ogihara D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Toshio Ogihara sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 128 D-Index — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in Japan Leader Award

Overview

Toshio Ogihara is affiliated with Osaka University in Japan and has contributed extensively to the field of Medicine, with a particular focus on Cardiology and Cardiovascular Medicine. Their research portfolio encompasses multiple subfields including Endocrinology, Diabetes and Metabolism, Molecular Biology, Complementary and Alternative Medicine, and Cancer Research.

Their work addresses several core topics, including:

  • Blood Pressure and Hypertension Studies
  • Heart Rate Variability and Autonomic Control
  • Hormonal Regulation and Hypertension
  • Diabetes Treatment and Management
  • Cardiac Health and Mental Health
  • Cancer, Lipids, and Metabolism
  • Cardiovascular Function and Risk Factors

Recent publications show a pattern of meta-analytical studies primarily focused on blood pressure and cardiovascular outcomes. Notable papers include:

  • Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis (2021, The Lancet)
  • Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis (2021, The Lancet)
  • Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis (2021, The Lancet Oncology)
  • Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis (2022, The Lancet Diabetes & Endocrinology)
  • Effects of ipragliflozin on left ventricular diastolic function in patients with type 2 diabetes and heart failure with preserved ejection fraction: The EXCEED randomized controlled multicenter study (2022, Geriatrics and gerontology international/Geriatrics & gerontology international)

Coauthorship patterns indicate frequent collaboration with researchers such as Hiromi Rakugi, Mark Woodward, Sverre E. Kjeldsen, Seiji Umemoto, and John Chalmers. This network reflects interdisciplinary cooperation in cardiovascular and metabolic research.

Several publication venues have hosted Ogihara's research, with multiple articles appearing in prestigious journals. Frequent venues include:

  • The Lancet
  • The Lancet Oncology
  • The Lancet Diabetes & Endocrinology
  • Geriatrics and gerontology international/Geriatrics & gerontology international
  • BMC Nursing

Best Publications

  • Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk

    Georg B. Ehret;Georg B. Ehret;Georg B. Ehret;Patricia B. Munroe;Kenneth M. Rice;Murielle Bochud

  • The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)

    Toshio Ogihara;Kenjiro Kikuchi;Hiroaki Matsuoka;Toshiro Fujita

  • In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction.

    Ryuichi Morishita;Toshiko Sugimoto;Motokuni Aoki;Iwao Kida

  • Hypoadiponectinemia Is an Independent Risk Factor for Hypertension

    Yoshio Iwashima;Tomohiro Katsuya;Kazuhiko Ishikawa;Noriyuki Ouchi

  • Novel Autologous Cell Therapy in Ischemic Limb Disease Through Growth Factor Secretion by Cultured Adipose Tissue–Derived Stromal Cells

    Hironori Nakagami;Kazuhisa Maeda;Ryuichi Morishita;Sota Iguchi

  • Association of Hypoadiponectinemia With Impaired Vasoreactivity

    Noriyuki Ouchi;Mitsuru Ohishi;Shinji Kihara;Tohru Funahashi

  • A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.

    R Morishita;G H Gibbons;M Horiuchi;K E Ellison

  • Local Delivery of Plasmid DNA Into Rat Carotid Artery Using Ultrasound

    Yoshiaki Taniyama;Katsuro Tachibana;Kazuya Hiraoka;Tsunetatsu Namba

  • Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia

    Ryuichi Morishita;Gary H. Gibbons;Kristin E. Ellison;Masatoshi Nakajima

  • Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians

    Norihiro Kato;Fumihiko Takeuchi;Yasuharu Tabara;Tanika N. Kelly

  • Erratum: The Japanese Society of hypertension guidelines for the management of hypertension (Hypertension Research (2009) 32 (11-23) DOI: 10.1038/hr.2008.2)

    Toshio Ogihara;Kenjiro Kikuchi;Hiroaki Matsuoka;Toshiro Fujita

  • Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

    Kazem Rahimi;Zeinab Bidel;Milad Nazarzadeh;Emma Copland

  • Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle

    Y Taniyama;K Tachibana;K Hiraoka;M Aoki

  • Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function

    Cristian Pattaro;Alexander Teumer;Mathias Gorski;Audrey Y. Chu

  • Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy.

    Hironori Nakagami;Ryuichi Morishita;Kazuhisa Maeda;Yasushi Kikuchi

  • Target Blood Pressure for Treatment of Isolated Systolic Hypertension in the Elderly: Valsartan in Elderly Isolated Systolic Hypertension Study

    Toshio Ogihara;Takao Saruta;Hiromi Rakugi;Hiroaki Matsuoka

  • Deletion of Angiotensin-Converting Enzyme 2 Accelerates Pressure Overload-Induced Cardiac Dysfunction by Increasing Local Angiotensin II

    Koichi Yamamoto;Mitsuru Ohishi;Tomohiro Katsuya;Norihisa Ito

  • Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides.

    R. Morishita;G. H. Gibbons;K. E. Ellison;M. Nakajima

  • Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives

    Toshio Ogihara;Hiromi Rakugi;Hiroshi Ikegami;Hiroshi Mikami

  • Pancreatic β Cell–specific Expression of Thioredoxin, an Antioxidative and Antiapoptotic Protein, Prevents Autoimmune and Streptozotocin-induced Diabetes

    Mizuo Hotta;Fumi Tashiro;Hiroshi Ikegami;Hitoshi Niwa

Frequent Co-Authors

Ryuichi Morishita
Ryuichi Morishita Osaka University
Hiromi Rakugi
Hiromi Rakugi Osaka University
Yasufumi Kaneda
Yasufumi Kaneda Osaka University
Tomohiro Katsuya
Tomohiro Katsuya Osaka University
Motokuni Aoki
Motokuni Aoki Morinomiya University of Medical Sciences
Takao Saruta
Takao Saruta Keio University
Toshikazu Nakamura
Toshikazu Nakamura Osaka University
Kazuaki Shimamoto
Kazuaki Shimamoto Sapporo Medical University
Kunio Matsumoto
Kunio Matsumoto Kanazawa University
Kei Yamamoto
Kei Yamamoto University of Tokushima

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring related online degrees and alternative career paths can provide prospective medical students with more flexibility and a faster route to entering the healthcare field. Many learners consider nursing programs as a stepping stone to medical careers, or as a fulfilling career in itself. For those seeking speedy advancement, the fastest dnp online program options help working nurses achieve a Doctor of Nursing Practice in the shortest possible time.

Learners interested in a more accessible path should consider easy dnp programs, which are designed to minimize barriers to admission and completion. If you're seeking to begin your healthcare journey quickly, a 9 month lpn program offers a streamlined pathway to becoming a Licensed Practical Nurse.

Mental health continues to be a vital focus in medicine. Those eager to specialize in this area may explore the shortest pmhnp program for a fast-track option to becoming a Psychiatric Mental Health Nurse Practitioner. These specialized, flexible online degrees provide diverse pathways to serve and impact the healthcare sector.

Best Scientists Citing Toshio Ogihara

Trending Scientists

Recently Published Articles